Ferritin at the Crossroads of Inflammation and Risk: Cardiometabolic Correlates in Acute Myocardial Infarction
International Journal of Pharmaceutical Quality Assurance · 30.06.2026 · 17 (06)
DOI: 10.25258/ijpqa.17.6.16 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Pharmaceutical Quality Assurance, online erschienen am 30.06.2026. Verfasst von LKV Kumar Kesamsetty und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Acute myocardial infarction (AMI) commonly occurs in individuals with multiple coexisting cardiovascular risk factors. Serum ferritin, apart from reflecting iron stores, is increasingly recognized as a marker of inflammation and metabolic dysfunction.
Aim
To determine the correlation between serum ferritin levels and risk factors such as hypertension, diabetes mellitus, dyslipidemia, smoking, and obesity in patients with AMI.
Methods
This prospective observational study was conducted in the Department of General Medicine, Great Eastern Medical School and Hospital, Ragolu, Srikakulam, Andhra Pradesh. A total of 107 patients with AMI were included. Clinical details, demographic variables, cardiovascular risk factors, and laboratory investigations including serum ferritin estimation by chemiluminescent immunoassay were recorded. Statistical analysis was performed using descriptive and inferential methods, and associations between ferritin levels and risk factors were assessed.
Results
Hypertension was the most frequent risk factor (64.5%), followed by smoking (63.6%), diabetes mellitus (59.8%), dyslipidemia (59.8%), and obesity (57.9%). Mean serum ferritin levels were significantly higher in patients with hypertension (377.85 vs 284.55 ng/mL, p=0.009), diabetes (392.45 vs 273.67 ng/mL, p=0.001), dyslipidemia (426.37 vs 223.18 ng/mL, p
Zitieren
APA
Kesamsetty, L. K., Bagadi, R., Baratam, S. T., & Pappala, P. (2026). Ferritin at the Crossroads of Inflammation and Risk: Cardiometabolic Correlates in Acute Myocardial Infarction. International Journal of Pharmaceutical Quality Assurance, 17(06). https://doi.org/10.25258/ijpqa.17.6.16
Vancouver
Kesamsetty LK, Bagadi R, Baratam ST, Pappala P. Ferritin at the Crossroads of Inflammation and Risk: Cardiometabolic Correlates in Acute Myocardial Infarction. International Journal of Pharmaceutical Quality Assurance. 2026;17(06). doi:10.25258/ijpqa.17.6.16
BibTeX
@article{Kesamsetty2026,
author = {Kesamsetty, LKV Kumar and Bagadi, Rachana and Baratam, Sai Teja and Pappala, Priyanka},
title = {Ferritin at the Crossroads of Inflammation and Risk: Cardiometabolic Correlates in Acute Myocardial Infarction},
journal = {International Journal of Pharmaceutical Quality Assurance},
year = {2026},
volume = {17},
number = {06},
doi = {10.25258/ijpqa.17.6.16}
}
EUVIMED